Clinical Trial Update: Generic VEL/SOF With or Without RBV for HIV/HCV Coinfected Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating generic Velpatasvir/sofosbuvir with or without ribavirin in HIV/HCV coinfected patients; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Human Immunodeficiency Virus Infection

Drugs mentioned

• Velpatasvir/sofosbuvir (generic) (Velpatasvir/sofosbuvir)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Hepatitis C Virus Infection, Response to Therapy of, Human Immunodeficiency Virus | Phase 4 | Status: COMPLETED